CAS: 38235-71-1; 3-Hydrazinylbenzoic Acid

该化合物是一种有机化合物,其特点是存在一个氢氨功能组和一个附于苯环的碳本酸组,该化合物一般是白色的脱白晶状固体,在水和酒精等极地溶剂中溶解,由于碳本酸和氢氨酸的盐碱的盐分性性质,这种化合物在碳本酸和氢氮酸糖的体温中具有溶解性,这种物质具有潜在的再活性,在各种化学合成和应用中,包括作为制药和农用化学品的一个建筑块,都有用.此外,3-hydazenzoic酸可能展示生物活动,可以用于潜在的治疗用途,其特性,如熔点,沸点和特定再活动,可以因纯度和环境条件而不同而不同.与许多氢子衍生物一样,安全防范措施应当因潜在的毒性和再活性而采取.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号99-05-8 间氨基苯甲酸 | CAS号7647-01-0 盐酸 | CAS号25116-40-9 m-carboxybenzen... | CAS号855196-97-3 3-isopropyliden... | CAS号7732-18-5 水 | CAS号90556-87-9 3-肼基苯甲酸乙酯 | CAS号1843-35-2 3-叠氮苯甲酸 | CAS号99-05-8 间氨基苯甲酸 | CAS号622-37-7 叠氮苯 | CAS号103027-96-9 吲哚-2,4-二甲酸 | CAS号729613-71-2 2, 3, 4, 9-四氢-1... | CAS号784143-99-3 6,7,8,9-tetrahy... | CAS号60297-63-4 3-(4,5-二氢-3-甲基-...

合成工艺路线路线简述

  • 合成目标产物 3-Hydrazinobenzoic Acid 主要起始原料 3-Aminobenzoic Acid
  • (文献来源)合成步骤主要原料 3-Aminobenzoic Acid
间氨基苯甲酸置于盐酸,Sodium Nitrite,Clh*cl2Sn体系中,用 水 作为反应溶剂,化学反应 0.67H,反应生成 3-肼基苯甲酸
参考文献:通过活性导向组合化学合成策略发现新型人磷酸甘油酸脱氢酶抑制剂
标题:通过活性导向组合化学合成策略发现新型人磷酸甘油酸脱氢酶抑制剂
摘要:丝氨酸是从头合成嘌呤和脱氧胸苷所必需的一碳单元的来源,在癌细胞的生长中起着至关重要的作用.磷酸甘油酸脱氢酶 (Phgdh) 催化丝氨酸从头生物合成中的第一个限速步骤,已成为治疗癌症的有希望的靶点.在这里,我们从基于酶促测定的内部小分子库的筛选中确定了h-G6作为潜在的 Phgdh 抑制剂.我们采用了活性导向的组合化学合成策略来优化这种命中化合物.发现化合物b36是非竞争性和最有前途的化合物,其对 Phgdh 的ic 50值为 5.96 +/-0.61 μm.化合物b36抑制人乳腺癌和卵巢癌细胞的增殖,减少细胞内丝氨酸合成,破坏dna合成,并诱导细胞周期停滞.总的来说,我们的结果表明b36是一种新型的 Phgdh 抑制剂,它可能是一种有前景的调节丝氨酸合成途径的调节剂,并且可能是一种潜在的抗癌先导物,值得进一步探索.
DOI:10.1016/j.Bioorg.2021.105159

海关参考信息

专利信息


专利号:US-11040938-B2
优先权日:2016-07-27
标 题 :Continuous flow process for the synthesis of phenylhydrazine salts and substituted phenylhydrazine salts
发明人:MA BING; PAN SHUAI
权利人:SHANGHAI HYBRID—CHEM TECH; SHANGHAI HYBRID CHEM TECH
摘要:The present invention provided a continuous flow process for the synthesis of phenylhydrazine salts and substituted phenylhydrazine salts. Diazotization, reduction, acidic hydrolysis and salifying with acids are innovatively integrated together. Using acidic liquids of aniline or substituted aniline, diazotization reagents, reductants and acids as raw materials, phenylhydrazine derivative salts is obtained through the synthesis process, which is a three-step continuous tandem reaction including diazotization, reduction, acidic hydrolysis and salifying. The described synthesis process is a kind of integrated solutions, which is carried out in an integrated reactor. The feed inlets of the integrated reactor are continuously filled with raw materials. In the integrated reactor, diazotization, reduction, acidic hydrolysis and salifying are carried out continuously and orderly, and phenylhydrazine salts or substituted phenylhydrazine salts is obtained in the outlet of the integrated reactor without interruption. The total reaction time is no more than 20 min.

专利号:US-2011263540-A1
优先权日:2008-07-25
标题 :Small-molecule inhibitors of protein synthesis inactivating toxins
发明人:PANG YUAN-PING; TUMER NILGUN EREKEN; MILLARD CHARLES B
权利人:PANG YUAN-PING; TUMER NILGUN EREKEN; MILLARD CHARLES B
摘要:Small-molecule inhibitors of a protein synthesis inhibiting toxin, e.g., ricin, abrin, Shiga, and Shiga-like toxins, as well as methods of using the inhibitors are provided. Further provided are methods of identifying small-molecule inhibitors of a protein synthesis inhibiting toxin.

专利号:US-2019152896-A1
优先权日:2016-07-27
标题 :Continuous Flow Process For the Synthesis of Phenylhydrazine Salts and Substituted Phenylhydrazine Salts

专利号:US-8030311-B2
优先权日:2005-04-14
标题:Phenylacetamides suitable as protein kinase inhibitors
发明人:BOLD GUIDO; FURET PASCAL; GUAGNANO VITO; MCCARTHY CLIVE; VAUPEL ANDREA
权利人:NOVARTIS AG
摘要:The invention relates to compounds of the formula (I) wherein the moieties R1, R2, R3, R9, R10 and Q and X, Y and Z are as defined in the specification, and salts thereof, as well as their use, methods of use for them and method of their synthesis, and the like. The compounds are protein kinase inhibitors and can, inter alia, be used in the treatment of various proliferative diseases.

专利号:CN-107663161-A
优先权日:2016-07-27
标 题 :A kind of continuous flow synthesis process of phenylhydrazine salt and substituted phenylhydrazine salt

专利号:CN-110950848-B
优先权日:2018-09-27
标题 :Synthesis and Application of New Aminopyrazole Derivatives
安徽星宇化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.pyridinechem.com
企业联系电话:0555-2568883;13801504285;13961297163👤
📞安徽星宇化工有限公司 ⚠️参考联系方式
联系人:张升
电话:0555-2568883;13801504285;13961297163
手机:13801504285
传真:0555-2568988
邮箱:jvd@pyridinechem.com
通信地址: 安徽和县乌江镇安徽省精细化工园区
邮编: 213016
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:安徽和县乌江镇安徽省精细化工园区
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:H.H. Stroh and G. Westphal. Chem. Ber. 96, 184 (1963).
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知